68-3

111/130

Nakamura H, Kanai A, Bono H, Ono H, Eguchi H, Hirohashi N: GLIS1, a novel hypoxia-in-ducible transcription factor, promotes breast cancer cell motility via activation of WNT5A. Carcinogenesis, 2020; 41: 1184-1194.) Chikatani K, Chika N, Suzuki O, Sakimoto T, Ishibashi K, Eguchi H, Okazaki Y, Ishida H: Clinically applicable cases of anti-programmed cell death protein 1 immunotherapy for colorectal cancer patients. Surg Today, 2020; 50: 1694-1698.) Chikatani K, Chika N, Suzuki O, Sakimoto T, Ishibashi K, Eguchi H, Okazaki Y, Ishida H: A Model for Predicting DNA Mismatch Repair- deficient Colorectal Cancer. Anticancer Res, 2020; 40: 4379-4385. 6 7＊ 8) Ito T, Kono K, Eguchi H, Okazaki Y, Yama-moto G, Tachikawa T, Akagi K, Okada Y, Kawakami S, Morozumi M, Tamaru J-I, Ishida H: Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population. Jpn J Clin Oncol, 2020; 50: 80-88.＊ 9) Yatsuka Y, Kishita Y, Formosa LE, Shimura M, Nozaki F, Fujii T, Nitta KR, Ohtake A, Murayama K, Ryan MT, Okazaki Y: A homo-zygous variant in NDUFA8 is associated with developmental delay, microcephaly, and epilepsy due to mitochondrial complex I defi-ciency. Clin Genet, 2020; 98: 155-165. 10) Kishita Y, Shimura M, Kohda M, Akita M, Imai-Okazaki A, Yatsuka Y, Nakajima Y, Ito T, Ohtake A, Murayama K, Okazaki Y: A novel homozygous variant in MICOS13/QIL1 causes hepato-encephalopathy with mitochondrial DNA depletion syndrome. Mol Genet Genomic Med. 2020 Oct;8(10):e1427. 11) Takakuwa K, Mogushi K, Han M, Fujii T, Hosoya M, Yamanami A, Akita T, Yamashita C, Hayashida T, Kato S, Yamaguchi S: A novel diagnostic system to evaluate epidermal growth factor receptor impact as a prog-nostic and therapeutic indicator for lung adenocarcinoma. Sci Rep, 2020; 10: 6214. 12) Nakano K, Kawachi H, Chino A, Kita M, Arai M, Ide D, Saito S, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Fujisaki J: Phenotypic variations of gastric neoplasms in familial adenomatous polyposis are associated with endoscopic status of atro-phic gastritis. Digestive Endoscopy, 2020, 64: 547-556. 13) Inuzuka M, Watanabe C, Yokoyama S, Kuwayama T, Akashi-Tanaka S, Arai M, Nakamura S: Registration Committee of the Japanese HBOC consortium. A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan. Clin Breast Cancer, 2020; 21: e48-e52. 14) Mitamura T, Sekine M, Arai M, Shibata Y, Kato M, Yokoyama S, Yamashita H, Watari H, Yabe I, Nomura H, Enomoto T, Nakamura S; Registration Committee of the Japanese HBOC Consortium: Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome. Jpn J Clin Oncol, 2020; 50: 1380-1385. 15) Horimoto Y, Thinzar Hlaing M, Saeki H, Kitano S, Nakai K, Sasaki R, Kurisaki-Arakawa A, Arakawa A, Otsuji N, Matsuoka S, Tokuda E, Arai M, Saito M: Microsatellite instability and mismatch repair protein expressions in lympho-cyte-predominant breast cancer. Cancer Sci, 2020; 111: 2647-2654. 16) Kaneyasu T, Mori S, Yamauchi H, Ohsumi S, Ohno S, Aoki D, Baba S, Kawano J, Miki Y, Matsumoto N, Nagasaki M, Yoshida R, Akashi-Tanaka S, Iwase T, Kitagawa D, Masuda K, Hirasawa A, Arai M, Takei J, Ide Y, Gotoh O, Yaguchi N, Nishi M, Kaneko K, Matsuyama Y, Okawa M, Suzuki M, Nezu A, Yokoyama S, Amino S, Inuzuka M, Noda T, Nakamura S: Prevalence of disease-causing genes in Japanese patients with BRCA1/2- wildtype hereditary breast and ovarian cancer syndrome. NPJ Breast Cancer, 2020; 6: 25. 17) Yasuoka Y, Matsumoto M, Yagi K, Okazaki Y: Evolutionary history of GLIS genes illumi-nates their roles in cell reprogramming and ciliogenesis. Mol. Biol. Evol., 2020; 37: 100-109. 18) Ohki J, Sakashita A, Aihara E, Inaba A, Uchi-yama H, Matsumoto M, Ninomiya Y, Yamane T, Oishi Y, Iwatsuki K: Comparative analysis of enteroendocrine cells and their hormones between mouse intestinal organoids and native tissues. Biosci. Biotechnol. Biochem, 2020; 84: 307